ANEMIA PATTERN IN PATIENTS WITH CHRONIC KIDNEY DISEASES PRESENTED AT TERTIARY CARE HOSPITAL

Authors

  • MK KHAN Department of pediatrician khyber teaching hospital, Peshawar, Pakistan
  • H KHALIL Rehman medical institute Peshawar, Pakistan
  • MO FAROOQ Shifa International Hospital, Islamabad, Pakistan
  • SN IQBAL Fauji Foundation Hospital, Rawalpindi, Pakistan
  • A ALI Department of Biology, Govt. Degree College, Yarhussain, Swabi, Higher Education Department, KPK, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1068

Keywords:

Chronic Kidney Disease, Anemia, Normochromic Anemia, Hypochromic Anemia, Macrocytic Anemia, eGFR, Hemoglobin

Abstract

Anemia is a common complication in patients with chronic kidney disease (CKD) and contributes significantly to morbidity. Understanding the patterns and severity of anemia within this population can guide more effective management strategies. Objective: To assess the pattern and severity of anemia in patients with chronic kidney disease. Methods: This cross-sectional study was conducted from January 2024 to July 2024, involving 250 anemic CKD patients aged 18 years and above. The study was carried out at a nephrology care facility, with participants selected based on predefined inclusion and exclusion criteria. Data on demographic information, laboratory profiles, and anemia patterns were collected. Anemia was classified into mild, moderate, and severe categories. Statistical analysis was performed using SPSS version 24 to establish associations between the severity of CKD and the type of anemia. Results: Among the patients, 59.2% had normochromic anemia, 18.8% had hypochromic anemia, and 14% had macrocytic anemia. Moderate anemia was the most prevalent severity, observed in 51.2% of cases, followed by mild anemia in 41.6% and severe anemia in 7.2%. A significant association was noted between the severity of CKD and the type of anemia, particularly with normochromic anemia being more prevalent in patients with moderate CKD. Conclusion: The study concludes that normochromic anemia is the most predominant pattern of anemia in CKD patients, followed by hypochromic and macrocytic anemia. These findings underscore the importance of regular monitoring and tailored anemia management in CKD patients to improve overall patient outcomes.

Downloads

Download data is not yet available.

References

Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. The lancet. 2021;398(10302):786-802.

Carney EF. The impact of chronic kidney disease on global health. Nature Reviews Nephrology. 2020;16(5):251-2.

Li J-H, Luo J-F, Jiang Y, Ma Y-J, Ji Y-Q, Zhu G-L, et al. Red blood cell lifespan shortening in patients with early-stage chronic kidney disease. Kidney and Blood Pressure Research. 2019;44(5):1158-65.

Cukor D, Peterson RA, Cohen SD, Kimmel PL. Depression in end-stage renal disease hemodialysis patients. Nature clinical practice Nephrology. 2006;2(12):678-87.

Huang K-W, Leu H-B, Luo J-C, Chan W-L, Hou M-C, Lin H-C, et al. Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis. Digestive diseases and sciences. 2014;59:807-13.

HUANG CC. Hepatitis in patients with end‐stage renal disease. Journal of gastroenterology and hepatology. 1997;12(9‐10):S236-S41.

Portolés J, Martín L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Frontiers in Medicine. 2021;8:642296.

Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Advances in therapy. 2021;38(1):52-75.

Shaheen FA, Souqiyyeh MZ, Al-Attar BA, Karkar A, Al Jazairi AMH, Badawi LS, et al. Prevalence of anemia in predialysis chronic kidney disease patients. Saudi Journal of Kidney Diseases and Transplantation. 2011;22(3):456-63.

Gluba-Brzózka A, Franczyk B, Olszewski R, Rysz J. The influence of inflammation on anemia in CKD patients. International journal of molecular sciences. 2020;21(3):725.

Wong MM, Tu C, Li Y, Perlman RL, Pecoits-Filho R, Lopes AA, et al. Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clinical kidney journal. 2020;13(4):613-24.

Ataga KI, Gordeuk VR, Agodoa I, Colby JA, Gittings K, Allen IE. Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis. PLoS One. 2020;15(4):e0229959.

Khanal P. Morphological Patterns Of Anemia In Patients With Chronic Kidney Disease In A Tertiary Care Hospital, Nepal. Journal of Manmohan Memorial Institute of Health Sciences. 2023;8(2):51-60.

Khan AM, Afridi M, Ali G, Idrees M, Waqas M. Prevalence of anemia in chronic kidney disease patients in lady reading hospital, Peshawar. Khyber J Med Sci. 2018;11:439-42.

Mohammed MR, Mahmood B. Morphological Types of Anemia Associated with Chronic Renal Diseases. Open Access Macedonian Journal of Medical Sciences. 2022;10(B):905-8.

Downloads

Published

2024-09-02

How to Cite

KHAN, M., KHALIL, H., FAROOQ, M., IQBAL, S., & ALI, A. (2024). ANEMIA PATTERN IN PATIENTS WITH CHRONIC KIDNEY DISEASES PRESENTED AT TERTIARY CARE HOSPITAL. Biological and Clinical Sciences Research Journal, 2024(1), 1068. https://doi.org/10.54112/bcsrj.v2024i1.1068

Most read articles by the same author(s)

1 2 3 4 > >>